Skip to main content

Business

By Adam Ang | 02:23 am | August 22, 2025
After securing an additional $5 million in Series B funding, Naluri looks to enter the Philippines and Vietnam.
By HIMSS TV | 09:36 am | August 21, 2025
Sukrti Nagpal, deputy chief medical officer of virtual care provider Doccla, and Yosef Safi Harb, founder and CEO of health monitoring company Happitech, discuss how the companies are working together to help patients at home and physicians.
By Jessica Hagen | 04:53 pm | August 20, 2025
The company will use the funds to expand EHR and PBM integrations and partner with digital health and other companies to expand medication access.
By Anthony Vecchione | 04:34 pm | August 20, 2025
The Alzheimer's Disease Data Initiative is accepting applications for a $1 million first prize for agentic AI Alzheimer's research.
By HIMSS TV | 10:30 am | August 20, 2025
Dr. Deepti Pandita, UC Irvine Health CMIO & VP of Clinical Informatics, says that "if you don't have governance, anything can fall apart," and discusses the need to engage a diverse multi-stakeholder group to vet every AI project that is deployed.
By Jessica Hagen | 07:07 pm | August 18, 2025
The acquisition expands Teladoc's specialist network and presence in the region, while the company navigates ongoing financial challenges.
By Anthony Vecchione | 05:00 pm | August 18, 2025
CredAlliance aims to eliminate duplication of the credentialing process for providers.
By Anthony Vecchione | 02:58 pm | August 15, 2025
The financing comes on top of the company's $900 million annual research and development investment in the U.S.
By Anthony Vecchione | 12:51 pm | August 15, 2025
The company plans to launch the first version of its AI Advocate tool, aimed at helping patients manage and guide their overall healthcare, in the third quarter of this year.
By Jessica Hagen | 12:40 pm | August 15, 2025
The company's CEO defended its feature as a wellness tool under the 21st Century Cures Act, combating the FDA’s claim that it qualifies as a regulated medical device.